Skip to content

Analgesic Effectiveness of Thoracic Wall Nerve Blocks in Patients Undergoing Totally Implanted Venous Access Port

Analgesic Effectiveness of Thoracic Wall Nerve Blocks in Patients Undergoing Totally Implanted Venous Access Port

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087104
Enrollment
Unknown
Registered
2024-07-19
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who plan to undergo elective infusion port implantation surgery, male or female, aged 20-70 years, with a body mass index (BMI) of 17.9-24.9, ASA II-III, and NYHA I-III heart function classification.

Exclusion criteria

Exclusion criteria: Patients with chest malformation who can not receive nerve block, left ventricular ejection fraction less than 40%, history of diabetes, and infection.

Design outcomes

Primary

MeasureTime frame
Pain;

Secondary

MeasureTime frame
Intraoperative sedation evaluating with Steward score;The consumption of remifentanil and dexmedetomidine ;Sufentanil dosage ;

Countries

China

Contacts

Public ContactYang Zhang

The First Affiliated Hospital of Nanchang University

mzzhangyang@126.com+86 135 7608 0494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026